One American's Two-Year Quest to Move His Business Out of China
PHNOM PENH, Cambodia—For the first time in nearly two decades of visiting factories in Asia, Ryan Bursky's business trip didn't include a stop in China.
Until last year, his company's products—lamps and other lighting goods sold to retailers including Walmart and Home Depot—had been made in China. President Trump's first-term tariffs on Chinese goods pushed him to find an alternative.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Deal that reduced US tariffs on UK cars and aircraft parts comes into effect
(Reuters) -The trade deal signed between U.S. President Donald Trump and British Prime Minister Keir Starmer lowering some tariffs on imports from Britain has come into effect, the British government said on Monday. British car manufacturers will now be able to export to the U.S. under a reduced 10% tariff quota from an earlier 27.5%, while the current 10% tariffs were fully removed for goods like aircraft engines and aircraft parts, the statement said, reiterating details announced earlier in June. However, the issue of steel and aluminum tariffs remains unresolved. Britain has avoided tariffs of up to 50% on steel and aluminum that the U.S. imposed on other countries earlier this month, but it could face elevated tariffs starting July 9 unless a deal is reached. "... we will continue go further and make progress towards 0% tariffs on core steel products as agreed," the British statement added. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
Three Undiscovered Gems in Asia with Promising Potential
As global markets experience fluctuations, with U.S. indices reaching all-time highs and Asian markets showing resilience amid easing trade tensions, investors are increasingly turning their attention to the dynamic landscape of small-cap stocks in Asia. In this environment, identifying promising stocks often involves looking for companies that demonstrate strong fundamentals and potential for growth within sectors poised to benefit from evolving economic conditions. Name Debt To Equity Revenue Growth Earnings Growth Health Rating Bonny Worldwide 34.20% 17.05% 40.91% ★★★★★★ Taisun Enterprise 0.15% 6.44% 13.50% ★★★★★★ Luyin Investment GroupLtd 40.20% 6.14% 18.68% ★★★★★★ Zhejiang Haisen Pharmaceutical NA 4.06% 9.83% ★★★★★★ Jih Lin Technology 54.08% 1.96% 1.22% ★★★★★★ Shandong Sacred Sun Power SourcesLtd 19.09% 13.32% 42.32% ★★★★★★ Triocean Industrial Corporation 21.89% 47.09% 77.47% ★★★★★★ Kondotec 13.45% 7.00% 9.12% ★★★★★☆ Ningbo Henghe Precision IndustryLtd 66.02% 5.50% 23.91% ★★★★☆☆ Yuan Cheng CableLtd 88.11% 9.84% 42.67% ★★★★☆☆ Click here to see the full list of 2618 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. We'll examine a selection from our screener results. Simply Wall St Value Rating: ★★★★★☆ Overview: Hangzhou Advance Gearbox Group Co., Ltd. is involved in the production and sale of gearboxes and other related products both domestically in China and internationally, with a market capitalization of CN¥7.62 billion. Operations: The primary revenue stream for Hangzhou Advance Gearbox Group comes from its General Equipment Manufacturing segment, which generated CN¥2.33 billion. The company's market capitalization stands at CN¥7.62 billion. Hangzhou Advance Gearbox Group, a notable player in the machinery sector, has shown promising growth with a 22.1% earnings increase over the past year, outpacing industry averages. The company's price-to-earnings ratio of 31.5x is attractively lower than the broader CN market at 38.9x, suggesting potential value for investors. Over five years, their debt to equity ratio improved from 63.6% to a satisfactory 37.7%, reflecting prudent financial management. Recent earnings reveal steady progress with Q1 sales rising to CNY 451 million from CNY 423 million last year and net income slightly up at CNY 53 million compared to CNY 52 million previously. Click here and access our complete health analysis report to understand the dynamics of Hangzhou Advance Gearbox Group. Gain insights into Hangzhou Advance Gearbox Group's past trends and performance with our Past report. Simply Wall St Value Rating: ★★★★★☆ Overview: Xiamen Voke Mold & Plastic Engineering Co., Ltd. specializes in the production and sales of high-precision molds, injection products, and health products, with a market cap of CN¥8.34 billion. Operations: Voke Mold & Plastic Engineering generates its revenue primarily through the production and sales of high-precision molds, injection products, and health products, totaling CN¥2.03 billion. Xiamen Voke Mold & Plastic Engineering, a notable player in the machinery industry, showcases impressive growth with earnings surging 49.9% over the past year, outpacing its peers. The company's price-to-earnings ratio of 32.1x remains attractive compared to the broader CN market at 38.9x. Despite a volatile share price recently, Xiamen Voke's financial health is robust; it boasts more cash than total debt and covers interest payments comfortably. Recent earnings reports highlight significant revenue growth from CNY 328 million to CNY 539 million year-over-year for Q1 2025, with net income jumping from CNY 37 million to CNY 77 million during the same period. Click to explore a detailed breakdown of our findings in Xiamen Voke Mold & Plastic Engineering's health report. Understand Xiamen Voke Mold & Plastic Engineering's track record by examining our Past report. Simply Wall St Value Rating: ★★★★★☆ Overview: Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of health-related products, with a market cap of CN¥5.82 billion. Operations: Anhui Huaren Health Pharmaceutical derives its revenue primarily from the development and distribution of health-related products. The company's net profit margin is 15%, reflecting its efficiency in converting revenue into actual profit. Anhui Huaren Health Pharmaceutical has been on a growth trajectory, with earnings rising by 13.7% over the past year, outpacing the Consumer Retailing industry. Trading at nearly 88% below its estimated fair value, it presents a compelling valuation for potential investors. The company's financial health seems robust; it covers interest payments comfortably with EBIT at 16 times interest expenses and holds more cash than total debt. Recent amendments to its articles of association suggest strategic shifts, while consistent dividend payouts indicate shareholder-friendly policies. Despite high share price volatility recently, these factors collectively highlight its investment appeal in Asia's pharmaceutical sector. Unlock comprehensive insights into our analysis of Anhui Huaren Health Pharmaceutical stock in this health report. Evaluate Anhui Huaren Health Pharmaceutical's historical performance by accessing our past performance report. Reveal the 2618 hidden gems among our Asian Undiscovered Gems With Strong Fundamentals screener with a single click here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SHSE:601177 SZSE:301196 and SZSE:301408. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Chinese Robot Startup Reaps Rewards After High-Profile Race
(Bloomberg) -- Just a few months ago, Noetix Robotics was struggling to find a single customer for its Hobbit-sized robots. Founder Jiang Zheyuan was nervous about burning through investors' money quickly. Then one of its N2 models placed second in the world's first half-marathon for robots. Philadelphia Transit System Votes to Cut Service by 45%, Hike Fares Squeezed by Crowds, the Roads of Central Park Are Being Reimagined Sprawl Is Still Not the Answer Sao Paulo Pushes Out Favela Residents, Drug Users to Revive Its City Center Mapping the Architectural History of New York's Chinatown Now, the Beijing startup founded by the 27-year-old Tsinghua dropout is on track to deliver 2,000 robots by the end of the year. It's in talks to raise roughly $35 million at a $200 million valuation — about as much funding as it's secured since its inception in 2023. The company's staff has doubled to 100, with half of them working on a newly built production floor that churns out 10 bots per day, Jiang said in an interview. 'Most of our robots are sold after the marathon race,' Jiang told Bloomberg Television. 'The financial status of our company will be way better.' Noetix has undergone a profound transformation since the April race, which was broadcast across China. Its N2 robot, which costs about $6,000, accomplished what most of the field couldn't — it actually finished the race. The ensuing publicity drew interest from investors as well as a wide range of customers, from event planners to museums and research institutes. Prospective sales partners in Europe and the Middle East have also taken note. The startup's turnaround is emblematic of China's ambition to dominate the AI robot boom, part of President Xi Jinping's drive to reduce reliance on foreign technologies. Domestic leaders like Unitree and EngineAI are prepping their two-legged bots for increasingly complex roles, ranging from sorting garbage to patrolling the streets. Just this month, Hangzhou-based Unitree — whose founder attended a key meeting with Xi this year — received funding from investors including Tencent Holdings Ltd., Alibaba Group Holding Ltd., and a ByteDance Ltd.-backed venture firm. As the underdog, Noetix has to undercut its much more affluent rivals, Jiang said. The N2 is sold at less than half the rate of Unitree's popular G1 model, meaning Noetix has a below-market gross margin of just over 20%. Jiang likens this strategy to the early days of smartphone giant Xiaomi Corp., which lured away Chinese users of Apple Inc.'s iPhone with its budget handsets. Noetix is planning to open two new factories as it looks to ramp up production to 10,000 robots next year. The economies of scale could push the price even lower to eventually let every household afford a humanoid, its founder said. At the company's offices in Beijing's northern suburb of Changping, visitors are made to cover their phone cameras with a sticker. Jiang said he suspected IP theft after his back-flipping, marathon-racing bots shot to fame. Two years ago, the electronics engineer abandoned his PhD at China's top college to found Noetix with a high-school classmate. Last year, Noetix neared bankruptcy after Jiang got ahead of himself in expansion. But he's now more prudent on cost controls, while maintaining at least two years of cash runway and targeting a public listing in Hong Kong as soon as 2026. 'I can't just spend recklessly,' he said. Quitting his PhD was the right decision, he added, otherwise he might fall back on that as a safety net. Jiang has since raised money from some local governments and venture firms like Innoangel Fund. But Noetix still needs a contingency plan to deal with worsening tensions between the US and China. While most of the N2's components are made in China, Jiang's bots are powered by semiconductor chips from Intel Corp and STMicroelectronics NV. He's already sourced domestic substitutes in case of further US export controls. 'We are thinking about the extreme situation and we are having a plan B for that situation,' he said. Fresh off the marathon race, Noetix is already prepping its bots — including a yet-to-launch taller model to compliment the waist-height N2 — for a bigger sports event. In less than two months, they will compete at Beijing's Bird's Nest national stadium against other humanoids in gymnastics and track and field events. --With assistance from Jessica Sui. America's Top Consumer-Sentiment Economist Is Worried How to Steal a House Inside Gap's Last-Ditch, Tariff-Addled Turnaround Push Luxury Counterfeiters Keep Outsmarting the Makers of $10,000 Handbags Apple Test-Drives Big-Screen Movie Strategy With F1 ©2025 Bloomberg L.P.
